279 related articles for article (PubMed ID: 6317296)
1. Synergism of the antimicrobial agents miconazole, bacitracin and polymyxin B.
Cornelissen F; Van den Bossche H
Chemotherapy; 1983; 29(6):419-27. PubMed ID: 6317296
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of miconazole and polymyxin B on microbial pathogens.
Pietschmann S; Hoffmann K; Voget M; Pison U
Vet Res Commun; 2009 Aug; 33(6):489-505. PubMed ID: 19085068
[TBL] [Abstract][Full Text] [Related]
3. Is transmission electron microscopy (TEM) a promising approach for qualitative and quantitative investigations of polymyxin B and miconazole interactions with cellular and subcellular structures of Staphylococcus pseudintermedius, Escherichia coli, Pseudomonas aeruginosa and Malassezia pachydermatis?
Voget M; Lorenz D; Lieber-Tenorio E; Hauck R; Meyer M; Cieslicki M
Vet Microbiol; 2015 Dec; 181(3-4):261-70. PubMed ID: 26527257
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B.
Rosenthal KS; Storm DR
J Antibiot (Tokyo); 1977 Dec; 30(12):1087-92. PubMed ID: 202585
[TBL] [Abstract][Full Text] [Related]
5. In vitro interactions of neomycin sulfate, bacitracin, and polymyxin B sulfate.
Booth JH; Benrimoj SI; Nimmo GR
Int J Dermatol; 1994 Jul; 33(7):517-20. PubMed ID: 7928043
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates.
Boyen F; Verstappen KM; De Bock M; Duim B; Weese JS; Schwarz S; Haesebrouck F; Wagenaar JA
Vet Dermatol; 2012 Aug; 23(4):381-5, e70. PubMed ID: 22409321
[TBL] [Abstract][Full Text] [Related]
7. Polymyxin and Bacitracin in the Irrigation Solution Provide No Benefit for Bacterial Killing in Vitro.
Goswami K; Cho J; Foltz C; Manrique J; Tan TL; Fillingham Y; Higuera C; Della Valle C; Parvizi J
J Bone Joint Surg Am; 2019 Sep; 101(18):1689-1697. PubMed ID: 31567806
[TBL] [Abstract][Full Text] [Related]
8. The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries.
Pietschmann S; Meyer M; Voget M; Cieslicki M
Vet Dermatol; 2013 Aug; 24(4):439-45, e96-7. PubMed ID: 23721182
[TBL] [Abstract][Full Text] [Related]
9. Investigation of synergism with combinations of dibromopropamidine isethionate or propamidine isethionate and polymyxin B.
Richards MR; Xing DK
J Pharm Pharmacol; 1994 Jul; 46(7):563-6. PubMed ID: 7996383
[TBL] [Abstract][Full Text] [Related]
10. The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide.
Bang CS; Kinnunen A; Karlsson M; Önnberg A; Söderquist B; Persson K
BMC Microbiol; 2014 Mar; 14():65. PubMed ID: 24629000
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H
mBio; 2017 Sep; 8(5):. PubMed ID: 28874470
[No Abstract] [Full Text] [Related]
12. Mimicking an antimicrobial peptide polymyxin B by use of cyclodextrin.
Yamamura H; Suzuki K; Uchibori K; Miyagawa A; Kawai M; Ohmizo C; Katsu T
Chem Commun (Camb); 2012 Jan; 48(6):892-4. PubMed ID: 22143262
[TBL] [Abstract][Full Text] [Related]
13. Investigation of synergism between combinations of ciprofloxacin, polymyxin, sulphadiazine and p-aminobenzoic acid.
Richards RM; Xing DK
J Pharm Pharmacol; 1993 Mar; 45(3):171-5. PubMed ID: 8097773
[TBL] [Abstract][Full Text] [Related]
14. [The action of combinations of the nonapeptide polymyxin B with antibiotics on gram-negative bacteria].
Bairamashvili DI; Zinchenko AA; Maslin DN; Trakhanova MN; Miroshnikov AI
Antibiot Khimioter; 1988 Aug; 33(8):591-4. PubMed ID: 2848467
[TBL] [Abstract][Full Text] [Related]
15. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli.
Dixon RA; Chopra I
J Antimicrob Chemother; 1986 Nov; 18(5):557-63. PubMed ID: 3027012
[TBL] [Abstract][Full Text] [Related]
16. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
Jones RN; Li Q; Kohut B; Biedenbach DJ; Bell J; Turnidge JD
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):63-71. PubMed ID: 16368476
[TBL] [Abstract][Full Text] [Related]
17. [Effect of polymyxin B on ion permeability of bacterial membranes].
Kapitanova NG; Korepanova EA; Gariaev AA; Frolov VN; Antonov VF
Biofizika; 1981; 26(6):1100-2. PubMed ID: 6274432
[TBL] [Abstract][Full Text] [Related]
18. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
[TBL] [Abstract][Full Text] [Related]
19. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
[TBL] [Abstract][Full Text] [Related]
20. Clinical investigation of topical antimicrobials in healthy volunteers.
Langford JH; Benrimoj S
Ann Pharmacother; 1997 Jan; 31(1):34-8. PubMed ID: 8997462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
